Nurse Practitioner in Skagway, AK Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Carol J Borg, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 350 14th Ave, Skagway, AK 99840 Phone: 907-983-2255 Fax: 907-983-2793 |
Mrs. Andrea Leigh Payne, NP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1.7 Dyea Road, Skagway, AK 99840 Phone: 423-488-2345 |
Karen Johnston, Nurse Practitioner - Family Medicare: May Accept Medicare Assignments Practice Location: 350 14th Avenue, Skagway, AK 99840 Phone: 907-983-2255 |
News Archive
Newborn neurons in the adult brain can settle in the wrong neighborhood
In a study that could have significant consequences for neural tissue transplantation strategies, researchers at the Salk Institute for Biological Studies report that inactivating a specific gene in adult neural stem cells makes nerve cells emerging from those precursors form connections in the wrong part of the adult brain.
2006 yet 100 die in the Congo from the plague
According to the World Health Organization (WHO), as many as a hundred people have died in a suspected outbreak of pneumonic plague in the Democratic Republic of Congo.
Cancer incidence among women has increased slightly
Overall rates of cancer death for both men and women have declined in the United States, and cancer incidence has remained stable among men. However, overall cancer incidence among women has increased slightly, according to a special article that appears in the October 5 issue of the Journal of the National Cancer Institute.
Expert poll finds Afghanistan is the most dangerous place to be a woman
Afghanistan is the most dangerous place to be a woman because of high levels of poverty, poor health care and violence against female officials, according to a survey, the Guardian reports.
Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).
› Verified 3 days ago